
Promising treatment for chronic fatigue syndrome fails large trial
9 April 2019
Rituximab has been found to be worse than a placebo at alleviating the symptoms of CFS or ME, suggesting that antibodies aren’t to blame for the condition

9 April 2019
Rituximab has been found to be worse than a placebo at alleviating the symptoms of CFS or ME, suggesting that antibodies aren’t to blame for the condition

31 July 2017
The severity of chronic fatigue syndrome, also called myalgic encephomyelitis, has been linked to higher levels of 17 inflammation biomarkers in the blood